Cite
MLA Citation
M. Rucinska et al.. “SHARP hypofractionated stereotactic radiotherapy is low and intermediate-risk prostate carcinoma patients – PSA outcome.” European journal of cancer, vol. 72, n.d., pp. S193–S194. http://access.bl.uk/ark:/81055/vdc_100041522304.0x000047